BackChugai Pharmaceutical , Ltd. Overview

Chugai Pharmaceutical , Ltd. Current Cash

Track Chugai Pharmaceutical , Ltd.'s current cash ($390B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$387.62B
↓ 22.02% YoYΔ $-109.47B vs prior year quarter

Peer trimmed avg / median

Loading

Chugai Pharmaceutical , Ltd. Current Cash History

Loading

Chugai Pharmaceutical , Ltd. vs. peers: Current Cash Comparison

Loading

Chugai Pharmaceutical , Ltd. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chugai Pharmaceutical , Ltd. (CHGCY) FAQ

As of the most recent data (June 2026), CHGCY shows a current cash of $390B. That compares with $500B in the prior-year period — down 22.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHGCY's current cash is now $390B (was $500B) — a 22.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chugai Pharmaceutical , Ltd. is outperforming or lagging.

Tracking CHGCY's current cash over time shows whether Chugai Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $390B That compares with $500B in the prior-year period — down 22.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Chugai Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $390B) with ownership activity and broader fundamentals.